Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus.

Front Endocrinol (Lausanne) · 2025 · PMC12213378 · PMID 40607222

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

By Week 24, the Ebenatide group exhibited a reduction in TyG compared to baseline, though this change did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.